HCKT trades 23.0% below Wall Street's consensus target of $16.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HCKT achieves its forward estimates and maintains a stable P/E multiple of 9.3x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, The Hackett Group, Inc. (HCKT) has a Wall Street consensus price target of $16.50, based on estimates from 5 covering analysts. With the stock currently trading at $13.42, this represents a potential upside of +23.0%. The company has a market capitalization of $338M.
Analyst price targets range from a low of $16.00 to a high of $17.00, representing a 6% spread in expectations. The median target of $16.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, HCKT trades at a trailing P/E of 18.7x and forward P/E of 9.3x. The forward PEG ratio of 0.41 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +101.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $31.01, with bear and bull scenarios of $19.54 and $40.87 respectively. Model confidence stands at 41/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 FORRForrester Research, Inc. | $171M | $8.83 | — | — | Hold | 11.1x | 4 |
 CRAICRA International, Inc. | $1.3B | $197.66 | $194.00 | -1.9% | Buy | 24.0x | 1 |
 HURNHuron Consulting Group Inc. | $2.7B | $166.82 | $216.50 | +29.8% | Buy | 18.0x | 9 |
 ICFIICF International, Inc. | $1.4B | $79.68 | $110.00 | +38.1% | Buy | 11.2x | 13 |
 MANUManchester United plc | $3.9B | $22.61 | $17.95 | -20.6% | Hold | — | 10 |
 EXLSExlService Holdings, Inc. | $6.5B | $43.15 | $45.33 | +5.1% | Buy | 18.3x | 19 |
 ACNAccenture plc | $159.4B | $260.50 | $230.05 | -11.7% | Buy | 18.8x | 53 |
 GGenpact Limited | $7.2B | $42.27 | $40.50 | -4.2% | Hold | 10.3x | 40 |
 ITGartner, Inc. | $12.7B | $190.10 | $193.57 | +1.8% | Hold | 12.6x | 18 |
 MANManpowerGroup Inc. | $2.1B | $44.50 | $52.14 | +17.2% | Hold | 12.4x | 29 |
Quick answers to the most common questions about buying HCKT stock.
The consensus Wall Street price target for HCKT is $16.5, representing 23.0% upside from the current price of $13.42. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
HCKT has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $16.5 implies 23.0% upside from current levels.
With a forward P/E of 9.2763x, HCKT trades at a relatively low valuation. The consensus target of $16.5 implies 23.0% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $17 for HCKT, while the most conservative target is $16. The consensus of $16.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $41 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
HCKT is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HCKT stock forecast based on 5 Wall Street analysts shows a consensus price target of $16.5, with estimates ranging from $16 (bear case) to $17 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $31, with bear/bull scenarios of $20/$41.
Our quantitative valuation model calculates HCKT's fair value at $31 (base case), with a bear case of $20 and bull case of $41. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 41/100.
HCKT trades at a forward P/E ratio of 9.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on HCKT, with a "Buy" consensus rating and $16.5 price target (23.0% upside). 5 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HCKT analyst price targets range from $16 to $17, a 6% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $16.5 consensus represents the middle ground. Our model's $20-$41 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.